Glycoxidative and nitrosative stress in kidney of experimental diabetic rats: Effects of the prydoindole antioxidant stobadine

Neuroendocrinology Letters

Volumn 31, Issue 3, 2010, Pages 313-318

  Cumaoglu, Ahmet ^a   Stefek, Milan ^b   Bauer, Viktor ^b   Ari, Nuray ^c   Aricioglu, Aysel ^a   Karasu, Cimen ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Diabetes; Nitrotyrosine; Protein oxidation; Renal tissue; Stobadine

Indexed keywords

3 NITROTYROSINE; ADVANCED OXIDATION PROTEIN PRODUCT; GLUCOSE; STOBADINE; 3-NITROTYROSINE; ADVANCED GLYCATION END PRODUCT; ANTIOXIDANT; CARBOLINE DERIVATIVE; DICARBINE; GLUCOSE BLOOD LEVEL; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; KIDNEY PARENCHYMA; MALE; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RAT; STREPTOZOCIN DIABETES; ANALOGS AND DERIVATIVES; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; KIDNEY; METABOLISM; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; CARBOLINES; DIABETES MELLITUS, EXPERIMENTAL; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; MALE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; TYROSINE;

EID: 77955457432     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Agardh CD, Israelsson B, Thuesen-Olesen B, Agardh E (2002). Application of Quantitative Competitive Polymerase Chain Reaction for Measurements of mRNA From Antioxidative Enzymes in the Diabetic Rat Retina and Kidney. Metabolism. 51: 1279-1284. (Pubitemid 35174149)
2. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A (2001). Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem. 34: 65-70.
3. Beckman, J.S (2002). Protein tyrosine nitration and peroxynitrite. FASEB J. 16: 1144.
4. Cederberg SB and Eriksson UJ (2001). Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia. 44: 766-774.
5. Craven PA, Mehlem MF, Phillips SL, DeRubertis FR (2001). Overexpression of Cu21/Zn21 Superoxide Dismutase Protects Against Early Diabetic Glomerular Injury in Transgenic Mice. Diabetes. 50: 2114-2125.
6. Crouch R, Kimsey G, Priest DG, Sarda A, Buse MG (1978). Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetologia. 15: 53-57. (Pubitemid 8363626)
7. Cumaoglu A, Cevik C, Rackova L, Ari N, Karasu C (2007). Effects of antioxidant stobadine on protein carbonylation, advanced oxidation protein products and reductive capacity of liver in streptozotocin-diabetic rats: role of oxidative/nitrosative stress. Biofactors. 30: 171-178.
8. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A (2003). Protein carbonylation in human diseases. Trends Mol Med. 9: 169-176.
9. de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP (1999). Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med. 6: 202-226.
10. Derubertis FR, Craven PA (1994). Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes. 43: 1-8.
11. Drel VR, Pacher P, Stevens MJ, Obrosova IG (2006). Aldose reductase inhibition counteracts nitrosative stress and poly (ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells. Free Radic Biol Med. 15: 1454-1465.
12. Ghahary A, Luo JM, Gong YW, Chakrabarti S, Sima AA, Murphy LJ (1989). Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes. 38: 1067-1071. (Pubitemid 20015060)
13. Goldberg HJ, Whiteside Cl, Fantus IG (2002). The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta. J Biol Chem. 13: 33833-33841.
14. Grune T (2002). Oxidants and antioxidative defense. Hum Exp Toxicol. 21: 61-62.
15. Gumieniczek A, Hopkala H, Wójtowicz Z, Nikołajuk J (2002). Changes in antioxidant status of heart muscle tissue in experimental diabetes in rabbits. Acta Biochim Pol. 49: 529-535. (Pubitemid 135686799)
16. Horáková L, Stolc S (1998). Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen Pharmacol. 30: 627-638. (Pubitemid 28167763)
17. Ischiropoulos H, al-Mehdi AB (1995). Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 15: 279-282.
18. Kalousová M, Skrha J, Zima T (2002). Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res. 51: 597-604. (Pubitemid 36168668)
19. Kavak S, Ayaz L, Emre M, lnal T, Tamer L, Günay I (2008). The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic rats. Cell Biochem Funct. 26: 478-485.
20. Kowluru RA, Odenbach S (2004). Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes. 12: 3233-3238.
21. Kyselova Z, Gajdosik A, Gajdosikova A, Ulicna O, Mihalova D, Karasu et al. (2005). Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT. Mol Vis. 11: 56-65.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem. 193: 265-275.
23. Mak DH, Ip SP, Li PC, Poon MK, Ko KM (1996). Alterations in tissue glutathione antioxidant system in streptozotocin-induced diabetic rats. Mol Cell Biochem. 162: 153-158.
24. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW, Fukami K, Yamagishi et al. (2008). Role of AGEs in diabetic nephropathy. Curr Pharm Des. 14: 946-952.
25. Pacher P, Obrosova IG, Mabley JG, Szabó C (2005). Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem. 12: 267-275.
26. Pieper GM, Jordan M, Dondlinger LA, Adams MB, Roza AM (1995). Peroxidative stress in diabetic blood vessels. Reversal by pancreatic islet transplantation. Diabetes. 44: 884-9.
27. Rauscher FM, Sanders RA, Watkins JB (2001). Effects of Coenzyme Q10 Treatment on Antioxidant Pathways in Normal and Streptozotocin-induced DiabeticRats. J Biochem Mole Toxicol. 15: 41-46
28. Reznick AZ, Packer L (1994). Oxidative damage to proteins: spectrophotometry method for carbonyl assay. Methods Enzymol. 233: 357-363 (Pubitemid 24177561)
29. Rysz J, Błaszczak R, Banach M, Kedziora-Kornatowska K, Kornatowski T, Tanski W, Kedziora J (2007). Evaluation of selected parameters of the antioxidative system in patients with type 2 diabetes in different periods of metabolic compensation. Arch Immunol Ther Exp (Warsz) 55: 335-340.
30. Sakurai T, Tsuchiya S (1998). Superoxide production from nonenzymatically glycated protein. FEBS Lett. 29: 406-410.
31. Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan et al. (1997). Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia. 40: 23-29.
32. Stefek M, Gajdosik A, Tribulova N, Navarova J, Volkovova K, Weismann et al. (2002). The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats. Methods Find Exp Clin Pharmacol. 24: 565-571.
33. Stefek M, Krizanova L, Trnkova Z (1999). Oxidative modification of serum albumin in an experimental glycation model of diabetes mellitus in vitro: effect of the pyridoindole antioxidant stobadine. Life Sci. 65: 1995-1997.
34. Stefek M, Kyselova Z, Rackova L, Krizanova L (2005). Oxidative modification of rat eye lens proteins by peroxyl radicals in vitro: protection by the chain-breaking antioxidants stobadine and Trolox. Biochim Biophys Acta. 1741: 183-190.
35. Strosova M, Tomaskova I, Ponist S, Bauerova K, Karlovska J, Spickett C, Horakova L (2008). Oxidative impairement of plasma and skeletal muscle sarcoplasmic reticulum in rats with adjuvant arthrithis - effects of pyridoindole antioxidants. Neuroendocrinol Lett. 29: 706-711.
36. Suarez-Pinzon WL, Szabó C, Rabinovitch A (1997). Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes. 46: 907-911. (Pubitemid 27188272)
37. Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy GB (2005). Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci. 46: 2092-2099.
38. Suzuki D, Miyata T (1999). Carbonyl stress in the pathogenesis of diabetic nephropathy. Intern Med. 38: 309-314.
39. Szabó C, Mabley JG, Moeller SM, Shimanovich R, Pacher P, Virag et al. (2002). Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FPI5, a novel potent peroxynitrite decomposition catalyst. Mol Med. 8: 571-580.
40. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996). Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49: 1304-1313.
41. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B (1998). Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 161: 2524-2532.
42. Yülek F, Or M, Ozoǧul C, Isik AC, Ari N, Stefek et al. (2007). Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress. Arch Med Res. 38: 503-511.
43. Zurova-Nedelcevova J, Navarova J, Drabikova K, Jancinova V, Petrikova M, Bernatova I, Kristova V, Snirc V, Nosalova V, Sotnikova R (2006). Participation of reactive oxygen species in diabetes-induced endothelial dysfunction. Neuroendocrinol Lett. 27: 168-171.